Верховный суд не захотел пересматривать спор AstraZeneca и «Акрихина»

The Supreme Court of Russia has declined to review the dispute between pharmaceutical companies AstraZeneca and Akrikhin. The case concerns the alleged illegal use of AstraZeneca's trade secrets by Akrikhin. This decision upholds the lower court's ruling, which previously sided with AstraZeneca. The legal battle has been ongoing for some time, involving allegations of intellectual property infringement.

This ruling is significant as it impacts intellectual property rights and fair competition within the pharmaceutical industry.